What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population.
Kim PauwelsIsabelle HuysMinne CasteelsYvonne DenierMartina VandebroekSteven R A SimoensPublished in: Applied health economics and health policy (2020)
This study has shown that gain in quality of life with cancer medicines is valued higher by Belgian society for patients who have lower initial quality of life before the start of treatment.